About Us
+
About PCI Synthesis
How to Select a CMO
New England Locations
Events
Client Testimonials
Awards
Affiliations
R&D and Analytics
+
Research & Development
Preclinical/Kilo Scale
Reaction Technologies
Analytical and Quality Control
API Manufacturing
+
API Manufacturing at PCI Synthesis
API Manufacturing Capacity
Controlled Substance API manufacturing
Cryogenic API Manufacturing
API Phase I – III
Commercial API Production
Quality Assurance / Regulatory
c
GMP Medical Grade Polymers
Advanced Materials
Products
+
News
+
Articles
Press Releases
Blog
Video
Chemistry
Contact Us
+
Get in Touch
Newsletter Sign-up
Download Our Brochure
Confidential Disclosure Agreement
Careers
+
View all open positions
Contact Human Resources
About Us
About PCI Synthesis
How to Select a CMO
New England Locations
Events
Client Testimonials
Awards
Affiliations
R&D and Analytics
Research & Development
Preclinical/Kilo Scale
Reaction Technologies
Analytical and Quality Control
API Manufacturing
API Manufacturing at PCI Synthesis
API Manufacturing Capacity
Controlled Substance API manufacturing
Cryogenic API Manufacturing
API Phase I – III
Commercial API Production
Quality Assurance / Regulatory
c
GMP Medical Grade Polymers
Advanced Materials
Products
News
Articles
Press Releases
Blog
Video
Chemistry
Contact Us
Get in Touch
Newsletter Sign-up
Download Our Brochure
Confidential Disclosure Agreement
Careers
View all open positions
Contact Human Resources
Search for:
Search for:
(4aS,6R,8aS)- 5,6,9,10,11,12- hexahydro- 3-methoxy- 11-methyl- 4aH- [1]benzofuro[3a,3,2-ef] [2] benzazepin-6-ol
GALANTAMINE
Product #: 105357
CAS #: 68291-97-4
MW: 287.354
Purity: >98%